---
schema_version: "secwatch.filing_event.v1"
accession: "0001551152-26-000030"
form_type: "8-K"
ticker: "ABBV"
cik: "0001551152"
company_name: "AbbVie Inc."
filed_at: "2026-10-05T20:07:45+00:00"
generated_at: "2026-10-12T14:50:14.119281+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# AbbVie trims 2026 adjusted EPS guidance to $13.76-$13.96 on $216M Q3 IPR&D charge

## Summary
- Q3 2026 adjusted diluted EPS guidance cut to $3.73-$3.77 from $3.84-$3.88 after $216M pre-tax acquired IPR&D and milestones expense ($0.11/share).
- Full-year 2026 adjusted diluted EPS guidance lowered to $13.76-$13.96 from $13.87-$14.07, reflecting the same $0.11 Q3 impact.
- FY2026 acquired IPR&D and milestones expense now $1,251M versus $1,035M previously announced; AbbVie excludes any beyond-Q3 amounts as not reliably forecastable.
- Results for the quarter ended September 30, 2026 are not finalized and remain subject to financial statement closing procedures; final figures may differ.
- CFO Scott T. Reents signed the October 5, 2026 report; guidance detail is in Exhibit 99.1.

## SEC filing metadata
- accession: 0001551152-26-000030
- form_type: 8-K
- ticker: ABBV
- cik: 0001551152
- company_name: AbbVie Inc.
- filed_at: 2026-10-05T20:07:45+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000030/0001551152-26-000030-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000030/abbv-20261005.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001551152-26-000030
- JSON: https://secwatch.observer/filing/0001551152-26-000030.json
- Plain text: https://secwatch.observer/filing/0001551152-26-000030.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.